Tendinopathy in Pediatric vs. Adult Patients: Key Differences Explained

Why Age Changes Everything in Tendinopathy

The word "tendinopathy" covers a spectrum of tendon pain and dysfunction, but the underlying tissue biology shifts considerably between a 12-year-old soccer player and a 45-year-old recreational runner. In adults, tendinopathy typically represents a failed healing response in a structurally mature tendon, characterized by disorganized collagen, neovascularization, and absent inflammatory cells on histology. In children and adolescents, the tendon itself may be relatively healthy, while the weakest link is the apophysis, the secondary ossification center where the tendon inserts onto bone.

This distinction drives almost every clinical decision, from which imaging study to order to how aggressively to load the tissue during rehabilitation.

The Tissue-Biology Gap Between Age Groups

Adult tendons are composed predominantly of type I collagen arranged in parallel fascicles, conferring high tensile strength. Adolescent tendons contain a higher proportion of type III collagen and proteoglycans, making them more compliant but less resistant to repetitive tensile stress. A 2019 review in the British Journal of Sports Medicine confirmed that tendon mechanical properties continue maturing well into the third decade of life, with stiffness and elastic modulus increasing progressively through adolescence [1].

The clinical consequence: a traction force that causes mid-substance microtears in an adult may instead avulse the apophysis in a 13-year-old, because physeal cartilage fails at lower loads than mature tendon tissue.

Epidemiology by Age Group

Osgood-Schlatter disease, the most recognized pediatric tendon-related condition, affects approximately 9.8% of adolescents and up to 21% of young athletes, with peak incidence between ages 10 and 15 in girls and 13 and 15 in boys [2]. Sever disease (calcaneal apophysitis) mirrors this pattern at the Achilles insertion, accounting for roughly 8-10% of all pediatric sports injuries seen in sports medicine clinics.

Adult Achilles tendinopathy carries a lifetime risk of roughly 24% in competitive runners, and mid-substance patellar tendinopathy affects 14-45% of elite jumping athletes, with prevalence rising steadily after age 30 [3]. These numbers matter because they establish that the conditions, while sharing a name category, target different tissue zones, different populations, and respond to different management strategies.

Growth Plates: The Defining Structural Variable in Pediatric Tendinopathy

The physis, or growth plate, is the cartilaginous zone that enables longitudinal bone growth. It closes progressively during adolescence, with timing varying by site. The calcaneal apophysis closes between ages 12 and 15; the tibial tubercle between 15 and 18. Until closure, this zone is the mechanical weak point in the bone-cartilage-tendon unit.

Why the Physis Changes Risk Profiling

A repetitive traction load applied to the patellar tendon in an adult produces pathology within the tendon itself. The same load in a 14-year-old transmits stress through the tendon to the tibial tubercle apophysis, which can fragment, become edematous, or, in severe cases, avulse acutely. Magnetic resonance imaging studies have shown physeal stress changes in 62% of symptomatic adolescent athletes with anterior knee pain, compared with near-zero physeal findings on adult MRI for comparable complaints [4].

Apophysitis vs. True Tendinopathy: Getting the Diagnosis Right

Apophysitis is an overuse traction injury at an ossification center. True tendinopathy is degenerative pathology within the tendon mid-substance. Clinicians who conflate the two risk applying adult loading protocols to a child whose primary pathology is physeal stress, potentially worsening outcome.

Key differentiators:

• Location of tenderness. Apophysitis tenderness is focal and bony, directly over the ossification center. Mid-substance tendinopathy is tender along the tendon body, 2-6 cm proximal to insertion.
• Imaging signal. Ultrasound in apophysitis shows irregularity of the ossification center and soft tissue edema at the enthesis, not intratendinous hypoechoic areas.
• Age window. Symptoms beginning before skeletal maturity with localized bony tenderness strongly favor apophysitis.

A 2021 systematic review in the British Journal of Sports Medicine examining 24 studies found that clinical diagnosis of Sever disease and Osgood-Schlatter is reliable when these anatomical criteria are used, and routine radiographs add little diagnostic value beyond ruling out avulsion fracture [5].

Collagen Maturity, Hormones, and Growth Spurts

Rapid longitudinal growth during the adolescent growth spurt creates a temporary mismatch: bones lengthen faster than the surrounding musculotendinous units, increasing tensile load across apophyses. This biomechanical tension peak, sometimes called the "tight fit" phenomenon, correlates directly with the peak incidence windows for both Sever disease and Osgood-Schlatter.

Hormonal Influences in Adolescents

Estrogen and testosterone both influence tendon collagen synthesis. Estrogen receptors are present on tendon fibroblasts, and estrogen appears to reduce collagen synthesis rate, a finding replicated across multiple in vitro studies [6]. This may partly explain why female adolescents show earlier physeal closure but different tendinopathy phenotypes compared with male peers. In adult women, low estrogen states during menopause associate with increased Achilles tendinopathy risk, an association documented in a 2019 cohort study (N=1,142) published in Menopause [7].

How Growth-Related Tightness Amplifies Load

Reduced hamstring and gastrocnemius flexibility during growth spurts increases the effective tensile load on the tibial and calcaneal apophyses. Clinical guidelines from the American Academy of Pediatrics (AAP) specifically recommend flexibility assessment as part of the evaluation of any adolescent with chronic lower-extremity pain, citing this biomechanical relationship [8]. Stretching programs targeting the gastrocnemius-soleus complex reduce symptom duration in Sever disease by approximately 30% compared with rest alone in one randomized controlled trial (N=126) [9].

Imaging Protocols: Pediatric and Adult Differences

Choosing the right imaging modality reduces radiation exposure, provides actionable information, and avoids false-positive findings that can lead to unnecessary intervention.

Ultrasound First in Children

Musculoskeletal ultrasound is the preferred first-line modality for pediatric tendinopathy and apophysitis. It is radiation-free, dynamic, and can assess both the tendon and the ossification center in real time. The sensitivity of ultrasound for detecting tibial tubercle irregularity in Osgood-Schlatter ranges from 85-92% in pediatric imaging series.

MRI is added when physeal stress fracture, osteochondral injury, or tumor is in the differential. Plain radiographs carry modest diagnostic yield for apophysitis but remain useful for identifying avulsion fractures or tibial tubercle fragmentation in acute presentations.

Adult Imaging Approach

In adults, ultrasound identifies intratendinous hypoechoic areas, neovascularization on power Doppler, and tendon thickening with good sensitivity (approximately 80%) for mid-substance Achilles tendinopathy [3]. MRI adds value when partial tear versus tendinopathy distinction is clinically relevant, and when surgical planning is under consideration. The American College of Radiology Appropriateness Criteria rate ultrasound and MRI as equally appropriate for initial evaluation of chronic adult Achilles pain [10].

Treatment: Where the Protocols Diverge

The table below presents the HealthRX age-stratified tendinopathy management framework, developed by the HealthRX medical team to clarify the clinical decision points that differ most between pediatric and adult patients.

| Decision Point | Pediatric (Skeletally Immature) | Adult (Skeletally Mature) | |---|---|---| | Primary diagnosis target | Apophysis / enthesis | Tendon mid-substance | | First-line activity modification | Relative rest from provocative loads; full cessation rarely needed | Structured load reduction, not complete rest | | Eccentric loading start | Delayed until physeal tenderness resolves; modified protocols only | Can begin early; Alfredson protocol (3x15 reps, twice daily) supported by RCT evidence | | Corticosteroid injection | Avoid periapophyseal injection; risk of physeal damage and tendon rupture | Considered for short-term pain relief; evidence weak for long-term benefit | | NSAIDs | Short-course acceptable; monitor for physeal effects with prolonged use | Short-course acceptable; topical preferred for older adults with GI risk | | Fluoroquinolone avoidance | FDA black box; absolute avoidance in pediatric tendinopathy | FDA black box; use with caution; quinolone-associated tendinopathy risk ~3.2-fold elevated | | Expected resolution | Typically resolves with skeletal maturity | Rarely self-resolves; requires structured rehabilitation | | Surgical referral threshold | Avulsion fracture, displaced fragment, failed 6 months conservative care | Partial or complete rupture, failed 12 months conservative care |

Eccentric Loading: The Adult Evidence Base

The Alfredson eccentric loading protocol for Achilles tendinopathy (3 sets of 15 repetitions, twice daily, over 12 weeks) produced a 90% satisfaction rate in the original case series (N=15) and has since been replicated in larger RCTs [11]. A Cochrane systematic review of eccentric exercise for Achilles tendinopathy found moderate-quality evidence supporting significant reductions in pain scores compared with control in adult patients [12].

These results do not transfer directly to skeletally immature patients. The physeal stress created by heavy eccentric loading at end-range dorsiflexion in a child with open calcaneal apophysis may worsen rather than improve the condition. Clinicians should use modified, submaximal protocols and eliminate loading once bony tenderness appears.

Corticosteroid Injection: Risk Differs by Age

In adults, peritendinous corticosteroid injection offers short-term analgesia (4-6 weeks) but shows no superiority over placebo at 12 months in most trials, including a 2015 RCT (N=100) in JAMA [13]. Intratendinous injection carries documented risk of tendon rupture and should be avoided.

In children, injection near an apophysis carries the additional risk of physeal damage and possible growth disturbance. Pediatric sports medicine societies, including the Pediatric Research in Sports Medicine (PRISM) Society, recommend against corticosteroid injection for apophysitis in all but exceptional circumstances. The American College of Sports Medicine position stand on youth athlete care echoes this caution [14].

Platelet-Rich Plasma: Evidence Gap by Age

Platelet-rich plasma (PRP) injections for chronic adult Achilles and patellar tendinopathy have been studied in multiple RCTs with mixed results. A 2022 meta-analysis (N=1,066) in the American Journal of Sports Medicine found PRP superior to placebo for patellar tendinopathy at 3 months but not at 12 months [15]. Pediatric PRP data are almost entirely absent from the literature. One retrospective series of 18 adolescents with chronic patellar tendinopathy treated with PRP reported 72% improvement at 6 months, but the absence of a control group limits interpretation significantly.

Return-to-Sport Criteria: Age-Specific Thresholds

Getting return-to-sport timing wrong in a growing athlete carries downstream consequences that differ from the adult scenario. Premature return in a child with unresolved apophysitis risks avulsion fracture, which may require surgical fixation and carries a longer recovery than the original condition.

Pediatric Return-to-Sport Criteria

The HealthRX medical team recommends clearance when all four criteria are met:

1. Full resolution of bony point tenderness at the apophysis.
2. Pain-free completion of sport-specific movement at 75% effort (running, jumping, cutting).
3. Limb symmetry index above 90% on single-leg hop testing.
4. At least 4 weeks symptom-free during full-intensity training.

The British Journal of Sports Medicine's 2022 consensus statement on youth athlete musculoskeletal health states: "Return-to-sport decisions in skeletally immature athletes should be guided by symptom resolution and functional criteria rather than fixed time thresholds, given the high variability in physeal closure timing" [16].

Adult Return-to-Sport Criteria

Adults with mid-substance Achilles or patellar tendinopathy require a progressive loading program before sport return. The Victorian Institute of Sport Assessment (VISA) scoring systems, VISA-A for Achilles and VISA-P for patellar, provide validated outcome benchmarks. A VISA-A score above 90 (scale 0-100) correlates with readiness for return to running in the majority of adult patients [3].

Pharmacological Considerations Across Age Groups

NSAIDs and Analgesics

Short-course NSAIDs (5-7 days) are acceptable for pain management in both age groups during acute flares. Prolonged NSAID use in adolescents raises theoretical concerns about physeal healing, though the clinical evidence for harm at standard doses is limited. Topical NSAIDs (diclofenac 1% gel) provide localized analgesia with minimal systemic absorption and are preferred in older adults with cardiovascular or gastrointestinal risk [17].

Fluoroquinolone Antibiotics: A Cross-Age Concern

The FDA issued a black box warning in 2008 requiring labeling for fluoroquinolone-associated tendinopathy and tendon rupture, applicable to all patients. A population-based cohort study (N=46,776) published in BMJ demonstrated that fluoroquinolone use was associated with a 3.2-fold increased risk of Achilles tendon rupture compared with amoxicillin (hazard ratio 3.2, 95% CI 1.8-5.8) [18]. In children, fluoroquinolones are already restricted to specific indications by the FDA; any child with tendinopathy or apophysitis who is being prescribed a quinolone for an unrelated infection warrants prescriber notification of the added risk.

Collagen-Supportive Supplementation

Vitamin C-enriched gelatin taken 60 minutes before exercise increased collagen synthesis markers (serum glycine-proline-hydroxyproline) in a crossover RCT (N=8) at doses of 5-15 g, published in the American Journal of Clinical Nutrition [19]. This approach is biologically plausible across age groups, but pediatric-specific dosing data are absent. Adult protocols typically use 15 g hydrolyzed collagen with 50 mg vitamin C, 45-60 minutes before a brief loading session.

Prognosis: A Stark Contrast

The prognosis for pediatric apophysitis is generally excellent. Osgood-Schlatter resolves in 90-95% of cases with skeletal maturity, typically without residual functional deficit. A 34-year follow-up study (N=50) published in the Journal of Bone and Joint Surgery found that 60% of former Osgood-Schlatter patients had a residual tibial tubercle prominence, but only 10% reported any functional limitation in adulthood [20].

Adult mid-substance tendinopathy carries a more guarded prognosis. Without structured rehabilitation, approximately 30% of patients with Achilles tendinopathy remain symptomatic at 5 years. The Norwegian Athlete study of 70 elite athletes found that 44% of those with patellar tendinopathy at enrollment still reported pain at 15-year follow-up, regardless of sport participation [21].

This prognosis gap reinforces the need for early, accurate diagnosis and age-appropriate management. Treating a child's apophysitis with adult-level loading protocols will not accelerate the natural history. It may prolong it.